This page will address some of the history of lupron, TAP (Takeda Abbott Phamaceuticals), and Abbott. After a 31 year joint venture, Takeda and Abbott dissolved their partnership in 5/08, and lupron is now under Abbott's purview. Information related to FDA's initial approval of lupron in men and women can be found in my 'USA Draft Document'. Other documents pertain to TAP's propensity for off-label promotion of lupron, and TAP's ultimate guilty plea in Medicare billing fraud.

This page is under construction.